Nursing Homes Used COVID Meds Less Than Expected During Pandemic
Medically reviewed by Drugs.com.
By Cara Murez HealthDay Reporter
TUESDAY, July 18, 2023 -- While nursing home residents are at high risk for bad outcomes if they get COVID-19, use of antiviral treatments, such as monoclonal antibodies, was low through most of 2021 and 2022.
The authors of a new study, led by Brian McGarry, a health services researcher at the University of Rochester Medical Center in New York, called that fact alarming.
Using data from the U.S. Centers for Disease Control and Prevention National Healthcare Safety Network for May 2021 to December 2002, McGarry and collaborators at Harvard University found that just 18% of COVID-19 cases in nursing homes were treated with antiviral medicine.
Even after easier-to-administer and widely available oral treatments were authorized, only 1 in 4 nursing home residents received these life-saving medications, the investigators found.
The study considered more than 763,000 COVID-19 cases in more than 15,000 U.S. nursing homes. Everyone in a nursing home meets current clinical guidelines to be considered for antiviral treatment.
By the end of last year, however, 40% of nursing homes reported that they had never used any of the antiviral treatments. And for-profit and lower-quality facilities, as well as those with higher shares of Medicaid and non-white residents, were less likely to use antivirals, the study authors noted.
This likely contributed to disparities in COVID hospitalizations and deaths, the researchers suggested in a university news release.
The report was published online July 14 in the Journal of the American Medical Association.
Sources
- University of Rochester Medical Center, news release, July 14, 2023
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Further Support and Information on COVID-19
Read this next
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
FRIDAY, June 14, 2024 -- COVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the...
Expert Panel Develops New Definition of Long COVID
TUESDAY, June 11, 2024 -- A new proposed definition for Long COVID could help patients get the help they need, a new report from the National Academies of Sciences, Engineering...
Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine
MONDAY, June 10, 2024 -- An experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
